FITC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_FITC_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_A_FITC_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
  • N418_B_FITC_Neg_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and FITC N418 (top) or FITC Armenian hamster IgG isotype control (bottom).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
117305 50 µg 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117306 500 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  2. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Man SM et al. 2016. Cell. 167(2):382-396 . PubMed
  5. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  6. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  7. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  8. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  9. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  10. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  11. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  12. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  13. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  14. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  15. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  16. Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
  17. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  18. Zhu H, et al. 2018. Elife. 7:. PubMed
  19. Devenport SN, et al. 2021. JCI Insight. 6: . PubMed
  20. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  21. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  22. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  23. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  24. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  25. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  26. Pott J et al. 2018. Cell host & microbe. 23(2):191-202 . PubMed
  27. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  28. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  29. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  30. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  31. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  32. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  33. Schwartz AJ, et al. 2021. Nat Metab. 3:969. PubMed
  34. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  35. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  36. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  37. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  38. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  39. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  40. Mizraji* G, et al. 2013. J Vis Exp. 77: 50388. PubMed
  41. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  42. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  43. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  44. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  45. Jin R, et al. 2020. Mol Cancer Ther. . PubMed
  46. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  47. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  48. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  49. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  50. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  51. Shen J, et al. 2022. Mater Today Bio. 16:100416. PubMed
  52. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  53. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  54. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  55. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  56. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  57. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  58. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  59. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  60. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  61. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  62. Bharali D, et al. 2008. Nanomedicine. 4:311. PubMed
  63. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  64. Wan X, et al. 2018. Nature. 560:107. PubMed
  65. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  66. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  67. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  68. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  69. Xue RY, et al. 2019. Front Immunol. 10:1372. PubMed
  70. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  71. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  72. Mao L, et al. 2022. Front Immunol. 13:833418. PubMed
  73. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  74. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  75. Morris AB, et al. 2020. Immunity. 52(1):136-150.e6.. PubMed
  76. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  77. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  78. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  79. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  80. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  81. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  82. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
  83. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  84. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  85. Han W, et al. 2020. J Immunol. 205:1125. PubMed
  86. Feng Y, et al. 2022. J Nanobiotechnology. 20:193. PubMed
  87. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  88. Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed
  89. Bi E, et al. 2018. J Clin Invest. 128:4821. PubMed
  90. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  91. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  92. Miki Y, et al. 2022. JCI Insight. 7:. PubMed
  93. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  94. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  95. Jaiswal M, et al. 2014. J Leukoc Biol. 96:337. PubMed
  96. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  97. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  98. Chin R, et al. 2006. J Immunol. 177:290. PubMed
  99. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  100. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  101. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  102. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  103. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  104. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  105. Qin S, et al. 2018. Oncol Lett. 128:1283. PubMed
  106. Gu H, et al. 2021. Elife. 10:. PubMed
  107. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  108. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  109. Poncini C, et al. 2015. J Immunol. 195: 3311 - 3324. PubMed
  110. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  111. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  112. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  113. Barrera-Avalos C, et al. 2021. iScience. 24:103520. PubMed
  114. Jee JJ, et al. 2022. Nat Commun. 13:18. PubMed
  115. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  116. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  117. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  118. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  119. Li Z, et al. 2022. Evid Based Complement Alternat Med. 2022:7421265. PubMed
  120. Wang X, et al. 2022. Elife. 11:. PubMed
  121. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  122. Ang QY, et al. 2020. Cell. 181(6):1263-1275.e16. PubMed
  123. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  124. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  125. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  126. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  127. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  128. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  129. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  130. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  131. Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
  132. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  133. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  134. Bidet K, et al. 2019. NPJ Vaccines. 4:27. PubMed
  135. Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
  136. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  137. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
RRID
AB_313774 (BioLegend Cat. No. 117305)
AB_313775 (BioLegend Cat. No. 117306)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account